Status:
COMPLETED
Evaluation of Home Program and Telerehabilitation for the Treatment Process in Patients With Breast Cancer-Related Lymphedema
Lead Sponsor:
Marmara University
Conditions:
Breast Cancer Related Lymphedema
Telerehabilitation
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
During the Covid-19 pandemic, rehabilitation services for all patients were affected, and a term that was previously in use but gained popularity during the pandemic entered our vocabulary: 'Telerehab...
Detailed Description
Our study is a randomized single-blind prospective study. Patients aged 18 to 75 years with stage 1-2 lymphedema associated with breast cancer and upper extremity lymphedema, who had undergone breast ...
Eligibility Criteria
Inclusion
- Patients who had undergone breast surgery at least 3 months ago
- Had stage 1-2 lymphedema
- Had upper extremity lymphedema associated with breast cancer
Exclusion
- Signs of infection such as lymphangitis, cellulitis, fungal infections
- Those with documented lymph node metastases
- Those with bilateral lymphedema
- Those with other diseases affecting upper extremity functions
- Those with a history of previous surgery related to the upper extremity
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06065423
Start Date
September 1 2021
End Date
June 1 2023
Last Update
October 3 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Canan Şanal-Toprak
Istanbul, Turkey (Türkiye), 34899
2
Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation
Istanbul, Turkey (Türkiye)